Louise Chen

Stock Analyst at Scotiabank

(3.54)
# 790
Out of 5,182 analysts
293
Total ratings
47.74%
Success rate
22.81%
Average return

Stocks Rated by Louise Chen

Teva Pharmaceutical Industries
Jan 29, 2026
Maintains: Sector Outperform
Price Target: $35$40
Current: $31.26
Upside: +27.96%
Johnson & Johnson
Jan 22, 2026
Maintains: Sector Outperform
Price Target: $230$265
Current: $225.34
Upside: +17.60%
Bristol-Myers Squibb Company
Jan 9, 2026
Maintains: Sector Perform
Price Target: $53$60
Current: $57.78
Upside: +3.84%
Merck & Co.
Dec 4, 2025
Maintains: Sector Outperform
Price Target: $105$120
Current: $110.23
Upside: +8.86%
Regeneron Pharmaceuticals
Nov 24, 2025
Maintains: Sector Perform
Price Target: $650$770
Current: $744.44
Upside: +3.43%
Sarepta Therapeutics
Jun 6, 2025
Upgrades: Sector Outperform
Price Target: $80
Current: $20.98
Upside: +281.32%
Aclaris Therapeutics
May 9, 2025
Maintains: Sector Outperform
Price Target: $15$9
Current: $4.41
Upside: +104.08%
Edgewise Therapeutics
Apr 3, 2025
Downgrades: Sector Perform
Price Target: $50$14
Current: $30.64
Upside: -54.31%
Gain Therapeutics
Mar 7, 2025
Initiates: Sector Outperform
Price Target: $12
Current: $1.95
Upside: +515.38%
Innoviva
Mar 7, 2025
Initiates: Sector Outperform
Price Target: $55
Current: $23.36
Upside: +135.45%
Initiates: Sector Perform
Price Target: $55
Current: $69.22
Upside: -20.54%
Initiates: Sector Outperform
Price Target: $15
Current: $4.27
Upside: +251.29%
Initiates: Sector Outperform
Price Target: $50
Current: $128.64
Upside: -61.13%
Initiates: Sector Outperform
Price Target: $15
Current: $5.99
Upside: +150.42%
Initiates: Sector Outperform
Price Target: $17
Current: $36.61
Upside: -53.56%
Initiates: Sector Outperform
Price Target: $50
Current: $18.04
Upside: +177.16%
Initiates: Sector Outperform
Price Target: $30
Current: $7.95
Upside: +277.36%
Initiates: Sector Outperform
Price Target: $55
Current: $21.88
Upside: +151.37%
Reiterates: Overweight
Price Target: n/a
Current: $2.67
Upside: -
Reiterates: Overweight
Price Target: $160
Current: $41.20
Upside: +288.35%
Reiterates: Overweight
Price Target: n/a
Current: $59.72
Upside: -
Maintains: Overweight
Price Target: $200$240
Current: $197.38
Upside: +21.59%
Reiterates: Overweight
Price Target: $45
Current: $26.79
Upside: +67.97%
Reiterates: Overweight
Price Target: n/a
Current: $9.81
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $27.85
Upside: -
Reiterates: Overweight
Price Target: $885
Current: $868.27
Upside: +1.93%
Reiterates: Overweight
Price Target: n/a
Current: $5.22
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $28.62
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $15.33
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $5.45
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $13.25
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $13.93
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $0.93
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $1.00
Upside: -
Reiterates: Overweight
Price Target: $65
Current: $3.49
Upside: +1,762.46%
Reiterates: Overweight
Price Target: $5
Current: $2.45
Upside: +104.08%
Reiterates: Overweight
Price Target: $50
Current: $13.45
Upside: +271.75%
Reiterates: Overweight
Price Target: $50
Current: $23.42
Upside: +113.49%
Reiterates: Neutral
Price Target: $5
Current: $2.07
Upside: +141.55%
Maintains: Overweight
Price Target: $5$9
Current: $0.64
Upside: +1,309.55%
Initiates: Overweight
Price Target: $1,687,500
Current: $0.28
Upside: +602,463,305.93%
Maintains: Neutral
Price Target: $240$258
Current: $225.33
Upside: +14.50%
Maintains: Overweight
Price Target: $40$50
Current: $1.19
Upside: +4,101.68%
Initiates: Overweight
Price Target: $20
Current: $1.20
Upside: +1,566.67%
Initiates: Overweight
Price Target: $45
Current: $5.26
Upside: +755.51%